ViroPharma Inc., a homegrown global pharmaceutical company, is expanding at its Exton headquarters, nearly doubling its space and its local workforce with new, high-paying jobs.
The company will lease an additional 71,000 square feet of office space to accommodate planned growth and will add at least 151 new jobs to its existing 188 employees over the next three years. The company has about 350 employees worldwide.
ViroPharma received a $583,000 funding offer from the state Department of Community and Economic Development (DCED), including a $130,000 Pennsylvania First grant and $453,000 in Job Creation Tax Credits, according to DCED.
The Governor's Action Team, working with the Chester County Economic Development Council, coordinated the project.
“For us it is about growth,” say ViroPharma's President and CEP Vincent J. Milano. “We're committed to this area for the long-term and look forward to creating opportunities in this community.”
The Ben Franklin Technology Partners of Southeastern Pennsylvania investment portfolio company was founded in 1994 by a small team of entrepreneurial scientists in Exton and reported $544.4 million in 2011 sales.
The company says it is “poised for new levels of growth as we commercialize important life saving products; expand our presence into European markets; and work to develop novel treatment paradigms for … serious diseases.”
“ViroPharma is dedicated to providing new treatment options to potentially address these types of great unmet medical needs: serious diseases, with limited – if any – treatment options.”
Source: DCED and ViroPharma
Writer: Elise Vider